Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1988 1
1989 2
1993 1
1998 1
1999 3
2001 1
2002 1
2003 2
2004 1
2006 2
2007 2
2008 4
2009 1
2010 1
2011 1
2012 1
2013 1
2015 1
2017 4
2018 3
2019 1
2022 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

31 results

Results by year

Filters applied: . Clear all
Page 1
Glycine transporter type-1 and its inhibitors.
Harsing LG Jr, Juranyi Z, Gacsalyi I, Tapolcsanyi P, Czompa A, Matyus P. Harsing LG Jr, et al. Among authors: gacsalyi i. Curr Med Chem. 2006;13(9):1017-44. doi: 10.2174/092986706776360932. Curr Med Chem. 2006. PMID: 16611082 Review.
Phenotypical Screening on Neuronal Plasticity in Hippocampal-Prefrontal Cortex Connectivity Reveals an Antipsychotic with a Novel Profile.
Spedding M, Sebban C, Jay TM, Rocher C, Tesolin-Decros B, Chazot P, Schenker E, Szénási G, Lévay GI, Megyeri K, Barkóczy J, Hársing LG Jr, Thomson I, Cunningham MO, Whittington MA, Etherington LA, Lambert JJ, Antoni FA, Gacsályi I. Spedding M, et al. Among authors: gacsalyi i. Cells. 2022 Mar 31;11(7):1181. doi: 10.3390/cells11071181. Cells. 2022. PMID: 35406745 Free PMC article.
S29434, a Quinone Reductase 2 Inhibitor: Main Biochemical and Cellular Characterization.
Boutin JA, Bouillaud F, Janda E, Gacsalyi I, Guillaumet G, Hirsch EC, Kane DA, Nepveu F, Reybier K, Dupuis P, Bertrand M, Chhour M, Le Diguarher T, Antoine M, Brebner K, Da Costa H, Ducrot P, Giganti A, Goswami V, Guedouari H, Michel PP, Patel A, Paysant J, Stojko J, Viaud-Massuard MC, Ferry G. Boutin JA, et al. Among authors: gacsalyi i. Mol Pharmacol. 2019 Mar;95(3):269-285. doi: 10.1124/mol.118.114231. Epub 2018 Dec 19. Mol Pharmacol. 2019. PMID: 30567956 Free article.
A novel GABA(A) alpha 5 receptor inhibitor with therapeutic potential.
Ling I, Mihalik B, Etherington LA, Kapus G, Pálvölgyi A, Gigler G, Kertész S, Gaál A, Pallagi K, Kiricsi P, Szabó É, Szénási G, Papp L, Hársing LG, Lévay G, Spedding M, Lambert JJ, Belelli D, Barkóczy J, Volk B, Simig G, Gacsályi I, Antoni FA. Ling I, et al. Among authors: gacsalyi i. Eur J Pharmacol. 2015 Oct 5;764:497-507. doi: 10.1016/j.ejphar.2015.07.005. Epub 2015 Jul 11. Eur J Pharmacol. 2015. PMID: 26169564
Loop F of the GABAA receptor alpha subunit governs GABA potency.
Pálvölgyi A, Móricz K, Pataki Á, Mihalik B, Gigler G, Megyeri K, Udvari S, Gacsályi I, Antoni FA. Pálvölgyi A, et al. Among authors: gacsalyi i. Neuropharmacology. 2018 Jan;128:408-415. doi: 10.1016/j.neuropharm.2017.10.042. Epub 2017 Nov 3. Neuropharmacology. 2018. PMID: 29109059
Egis-11150: a candidate antipsychotic compound with procognitive efficacy in rodents.
Gacsályi I, Nagy K, Pallagi K, Lévay G, Hársing LG Jr, Móricz K, Kertész S, Varga P, Haller J, Gigler G, Szénási G, Barkóczy J, Bíró J, Spedding M, Antoni FA. Gacsályi I, et al. Neuropharmacology. 2013 Jan;64:254-63. doi: 10.1016/j.neuropharm.2012.07.017. Epub 2012 Jul 21. Neuropharmacology. 2013. PMID: 22824189
Selective inhibition of extra-synaptic α5-GABAA receptors by S44819, a new therapeutic agent.
Etherington LA, Mihalik B, Pálvölgyi A, Ling I, Pallagi K, Kertész S, Varga P, Gunn BG, Brown AR, Livesey MR, Monteiro O, Belelli D, Barkóczy J, Spedding M, Gacsályi I, Antoni FA, Lambert JJ. Etherington LA, et al. Among authors: gacsalyi i. Neuropharmacology. 2017 Oct;125:353-364. doi: 10.1016/j.neuropharm.2017.08.012. Epub 2017 Aug 12. Neuropharmacology. 2017. PMID: 28807671
The glycine transporter-1 inhibitors NFPS and Org 24461: a pharmacological study.
Harsing LG Jr, Gacsalyi I, Szabo G, Schmidt E, Sziray N, Sebban C, Tesolin-Decros B, Matyus P, Egyed A, Spedding M, Levay G. Harsing LG Jr, et al. Among authors: gacsalyi i. Pharmacol Biochem Behav. 2003 Mar;74(4):811-25. doi: 10.1016/s0091-3057(02)01078-x. Pharmacol Biochem Behav. 2003. PMID: 12667895
(Phenylpiperazinyl-butyl)oxindoles as selective 5-HT7 receptor antagonists.
Volk B, Barkóczy J, Hegedus E, Udvari S, Gacsályi I, Mezei T, Pallagi K, Kompagne H, Lévay G, Egyed A, Hársing LG Jr, Spedding M, Simig G. Volk B, et al. Among authors: gacsalyi i. J Med Chem. 2008 Apr 24;51(8):2522-32. doi: 10.1021/jm070279v. Epub 2008 Mar 25. J Med Chem. 2008. PMID: 18361484
31 results